Xue Xinying, Xue Qingliang, Wang Na, Zhang Lina, Guo Lina, Li Xinfu, Sun Junping, Wang Jianxin
The Respiratory Diseases Department of the Chinese PLA General Hospital, Beijing 100853, P.R. China.
Oncol Lett. 2012 Jan;3(1):234-237. doi: 10.3892/ol.2011.452. Epub 2011 Oct 19.
The diagnosis of synchronous multiple primary lung cancer (SMPLC) remains a formidable challenge. The aim of the present study was to identify useful clues for the clinical diagnosis of SMPLC, in particular for the early stages. The medical records of 10 patients diagnosed with SMPLC with different histological types were analyzed retrospectively. Chest computed tomography (CT) findings showed two pulmonary lesions in all patients. The two lesions displayed malignant characteristics of primary lung cancer. The levels of a number of tumor markers, including carcinoembryonic antigen, neuron-specific enolase, cytokeratin fragment 21-1, squamous cell carcinoma and CA125 increased in 2 patients. Auxiliary examinations of other physical sites in these patients did not show signs of neoplasm metastasis. Two tumors were separately staged and appropriate treatment was carried out based on the revised stage, which provided more benefits for SMPLC patients. The diagnosis of SMPLC might be delayed or mistaken owing to its similarity to neoplasm metastasis. A high index of awareness is required for the early diagnosis of this disease. The malignant characteristics of primary lung cancer in various lesions may be valuable clues for the diagnosis of SMPLC. Alterations in the levels of tumor markers may be a poor diagnostic tool for the detection of SMPLC. Separate biopsies for different pulmonary masses should be performed for clinical staging as soon as possible and reasonable treatment based on the stage should also be selected.
同步性多原发性肺癌(SMPLC)的诊断仍然是一项艰巨的挑战。本研究的目的是为SMPLC的临床诊断,尤其是早期诊断寻找有用线索。回顾性分析了10例诊断为不同组织学类型SMPLC患者的病历。胸部计算机断层扫描(CT)结果显示所有患者均有两个肺部病灶。这两个病灶表现出原发性肺癌的恶性特征。2例患者中,包括癌胚抗原、神经元特异性烯醇化酶、细胞角蛋白片段21-1、鳞状细胞癌和CA125在内的多种肿瘤标志物水平升高。这些患者其他身体部位的辅助检查未显示肿瘤转移迹象。对两个肿瘤分别进行分期,并根据修订后的分期进行适当治疗,这为SMPLC患者带来了更多益处。由于SMPLC与肿瘤转移相似,其诊断可能会延迟或有误。早期诊断这种疾病需要高度的警惕性。各个病灶中原发性肺癌的恶性特征可能是SMPLC诊断的有价值线索。肿瘤标志物水平的改变可能不是检测SMPLC的良好诊断工具。应尽快对不同肺部肿块进行单独活检以进行临床分期,并根据分期选择合理的治疗方法。